Editorial: Beware of Naïve q2, use True q2: Some Comments on QSAR Model Building and Cross Validation

E-ISSN： 1875-6697|14|1|5-6

ISSN： 1573-4099

Source： Current Computer - Aided Drug Design, Vol.14, Iss.1, 2018-03, pp. : 5-6

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Use of a (Quantitative) Structure-Activity Relationship [(Q)Sar] Model to Predict the Toxicity of Naphthenic Acids

By Frank Richard Sanderson Hans Kavanagh Richard Burnison B. Kent Headley John Solomon Keith

Journal of Toxicology and Environmental Health, Vol. 73, Iss. 4, 2010-01 ,pp. : 319-329

Taylor & Francis Ltd

Access to resources Recommend Favorite

On the Use of the Metric rm 2 as an Effective Tool for Validation of QSAR Models in Computational Drug Design and Predictive Toxicology

Mini Reviews in Medicinal Chemistry, Vol. 12, Iss. 6, 2012-01 ,pp. : 491-504

Bentham Science Publishers

Access to resources Recommend Favorite

Beware of External Validation! - A Comparative Study of Several Validation Techniques used in QSAR Modelling

Current Computer - Aided Drug Design, Vol. 14, Iss. 4, 2018-12 ,pp. : 284-291

Bentham Science Publishers

Access to resources Recommend Favorite

P/Q-type Ca 2+ channel defects in migraine, ataxia and epilepsy

By Ophoff R.A. Terwindt G.M. Frants R.R. Ferrari M.D.

Trends in Pharmacological Sciences, Vol. 19, Iss. 4, 1998-04 ,pp. : 121-127

Elsevier

Access to resources Recommend Favorite

CNS drugs prominent in NZ's Q2 new drug listings

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 317, 2001-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite